Regulatory - EBC46 Research Hub (Page 2)

Medical regulatory documents and FDA approval paperwork on a clinical desk

EBC-46

Stelfonta's FDA Approval: What the Regulatory Pathway Tells Us About EBC-46's Future

Stelfonta became the first tigilanol tiglate product approved by the FDA. Understanding its regulatory journey maps the path EBC-46 must follow for human approval.

Pharmaceutical laboratory drug development research representing FDA orphan drug designation process

EBC-46

Orphan Drug Designation and EBC-46: What It Means for Patients with Rare Cancers

EBC-46 has received Orphan Drug Designation from the FDA for specific rare cancers. Here's what that regulatory milestone actually means — and why it matters for patients.

See all